This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

15 - 17 June 2021
Virtual EventDelivered in CEST time zone

Post Market Surveillance: There’s No Time For Delay

Advance Your PMS Strategy From EU MDR Ready To EU MDR Steady

With Clarification On Notified Body Expectations And Strategic Advice From Leading Industry Experts

Do Your PMS Strategies Meet The New Requirements?

Progress Your Post Market Surveillance Strategy With Practical Advice

  • Otto Bock and Smith & Nephew feedback on PMS requirements for Class I-III devices.
  • Gain a better understanding of Notified Body requirements for PMS with feedback from IMQ.
  • Valoc advise on best practices for keeping technical documents up to date.


The Regulatory Requirements: Ensure Your Post Market Surveillance Is Compliant

  • Hear the latest updates on PSURs from GMED.
  • Assess the Post Market Clinical Follow-Up requirements with Bassil Akra, QUINQUE and TUV SUD 
  • Enforce a pro-active Post Market Surveillance system with advice from Phillips.  

Efficiencies To Help Streamline Your PMS

  • Optimise your Benefit vs Risk reports with guidance from Valoc, and Dare!!
  • Novocure advise on how to update your PMS System for effective product monitoring.
  • Ortho Clinical Diagnostics share guidance for achieving a robust Quality Management System.